The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Fukuoka, Japan
RMD Open. 2023 Jan;9(1). doi: 10.1136/rmdopen-2022-002819.
Japanese rheumatology and immunology have contributed to progress in the field and advancement of rheumatology, including postmarketing surveillance, development of IL-6-targeting therapy and concept of drug tapering, have accelerated in the 21st century. The 67th Annual Scientific Meeting of the Japan College of Rheumatology, held on Fukuoka on 24 April 2023-26 April 2023, will go ahead and beyond such an advancement. Profound discussion on future perspectives such as precision medicine, the elucidation of pathology and genome-based drug discovery by multilayered integration with various types of omics information, information on metabolome and proteome of blood metabolites, and database of target proteins and compounds for drug discovery will be discussed.
日本的风湿病学和免疫学为该领域的进展和风湿病学的进步做出了贡献，包括上市后监测、靶向 IL-6 治疗的发展和药物减量概念，在 21 世纪加速发展。2023 年 4 月 24 日至 26 日在福冈举行的第 67 届日本风湿病学会年会将在此基础上更进一步。会议将深入探讨精准医学等未来前景，通过与各种类型的组学信息多层次整合，阐明病理学和基于基因组的药物发现，探讨血液代谢物的代谢组学和蛋白质组学信息以及药物发现的靶蛋白和化合物数据库。
